Answers are grounded in this paper and cite their sources.
Our results provide evidence that BIM is involved in TKI-induced apoptosis in sensitive EGFR-mutant cells and that both attenuation of the up-regulation of BIM and resistance to gefitinib-induced apoptosis are seen in models that contain the common EGFR T790M and the novel L747S secondary resistance mutations. These findings also suggest that induction of BIM may have a role in the treatment of TKI-resistant tumors.
No takes yet. Share an insight, caveat, or question.
Costa et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: